BACKGROUND: The treatment of stroke is dependent on a narrow therapeutic time window that requires interventions to be emergently pursued. Despite recent "FAST" initiatives that have underscored "time is brain," many patients still fail to present within the narrow time window to receive maximum treatment benefit from advanced stroke therapies, including recombinant tissue plasminogen activator (tPA) and mechanical thrombectomy. The convergence of emergency medical services, telemedicine, and mobile technology, including transportable computed tomography scanners, has presented a unique opportunity to advance patient stroke care in the prehospital field by shortening time to hyperacute stroke treatment with a mobile stroke unit (MSU). SUMMARY: In this review, we provide a look at the evolution of the MSU into its current status as well as future directions. Our summary statement includes historical and implementation information, economic cost, and published clinical outcome and time metrics, including the utilization rate of thrombolysis. KEY MESSAGES: Initially hypothesized in 2003, the first MSUs were launched in Germany and adopted worldwide in acute, prehospital stroke management. These specialized ambulances have made the diagnosis and treatment of many neurological emergencies, in addition to ischemic and hemorrhagic stroke, possible at the emergency site. Providing treatment as early as possible, including within the prehospital phase of stroke management, improves patient outcomes. As MSUs continue to collect data and improve their methods, shortened time metrics are expected, resulting in more patients who will benefit from faster treatment of their acute neurological emergencies in the prehospital field.
BACKGROUND: The treatment of stroke is dependent on a narrow therapeutic time window that requires interventions to be emergently pursued. Despite recent "FAST" initiatives that have underscored "time is brain," many patients still fail to present within the narrow time window to receive maximum treatment benefit from advanced stroke therapies, including recombinant tissue plasminogen activator (tPA) and mechanical thrombectomy. The convergence of emergency medical services, telemedicine, and mobile technology, including transportable computed tomography scanners, has presented a unique opportunity to advance patient stroke care in the prehospital field by shortening time to hyperacute stroke treatment with a mobile stroke unit (MSU). SUMMARY: In this review, we provide a look at the evolution of the MSU into its current status as well as future directions. Our summary statement includes historical and implementation information, economic cost, and published clinical outcome and time metrics, including the utilization rate of thrombolysis. KEY MESSAGES: Initially hypothesized in 2003, the first MSUs were launched in Germany and adopted worldwide in acute, prehospital stroke management. These specialized ambulances have made the diagnosis and treatment of many neurological emergencies, in addition to ischemic and hemorrhagic stroke, possible at the emergency site. Providing treatment as early as possible, including within the prehospital phase of stroke management, improves patient outcomes. As MSUs continue to collect data and improve their methods, shortened time metrics are expected, resulting in more patients who will benefit from faster treatment of their acute neurological emergencies in the prehospital field.
Entities:
Keywords:
Emergency medical services; Mobile stroke unit; Prehospital stroke treatment; Stroke management; Thrombolysis
Authors: Russell Cerejo; Seby John; Andrew B Buletko; Ather Taqui; Ahmed Itrat; Natalie Organek; Sung-Min Cho; Lila Sheikhi; Ken Uchino; Farren Briggs; Andrew P Reimer; Stacey Winners; Gabor Toth; Peter Rasmussen; Muhammad S Hussain Journal: J Neuroimaging Date: 2015-07-14 Impact factor: 2.486
Authors: Matthias Wendt; Martin Ebinger; Alexander Kunz; Michal Rozanski; Carolin Waldschmidt; Joachim E Weber; Benjamin Winter; Peter M Koch; Erik Freitag; Jenrik Reich; Daniel Schremmer; Heinrich J Audebert Journal: Stroke Date: 2015-01-29 Impact factor: 7.914
Authors: Peter M Koch; Alexander Kunz; Martin Ebinger; Frederik Geisler; Michal Rozanski; Carolin Waldschmidt; Joachim E Weber; Matthias Wendt; Benjamin Winter; Katja Zieschang; Kerstin Bollweg; Sabina Kaczmarek; Matthias Endres; Heinrich J Audebert Journal: Stroke Date: 2016-06-21 Impact factor: 7.914
Authors: Ather Taqui; Russell Cerejo; Ahmed Itrat; Farren B S Briggs; Andrew P Reimer; Stacey Winners; Natalie Organek; Andrew B Buletko; Lila Sheikhi; Sung-Min Cho; Maureen Buttrick; Megan M Donohue; Zeshaun Khawaja; Dolora Wisco; Jennifer A Frontera; Andrew N Russman; Fredric M Hustey; Damon M Kralovic; Peter Rasmussen; Ken Uchino; Muhammad S Hussain Journal: Neurology Date: 2017-03-08 Impact factor: 9.910
Authors: Nathaniel R Ellens; Derrek Schartz; Redi Rahmani; Sajal Medha K Akkipeddi; Adam G Kelly; Curtis G Benesch; Stephanie A Parker; Jason L Burgett; Diana Proper; Webster H Pilcher; Thomas K Mattingly; James C Grotta; Tarun Bhalla; Matthew T Bender Journal: Front Neurol Date: 2022-05-09 Impact factor: 4.086
Authors: Sonu Bhaskar; Sian Bradley; Vijay Kumar Chattu; Anil Adisesh; Alma Nurtazina; Saltanat Kyrykbayeva; Sateesh Sakhamuri; Sebastian Moguilner; Shawna Pandya; Starr Schroeder; Maciej Banach; Daniel Ray Journal: Front Public Health Date: 2020-09-07
Authors: Matthew Tuson; Matthew Yap; Mei Ruu Kok; Bryan Boruff; Kevin Murray; Alistair Vickery; Berwin A Turlach; David Whyatt Journal: Int J Health Geogr Date: 2020-10-03 Impact factor: 3.918